生脉注射液辅助治疗支气管哮喘急性发作47例疗效观察

目的探讨生脉注射液辅助治疗支气管哮喘急性发作的临床效果。方法选择2008年1月至2009年12月92例支气管哮喘急性发作患者,随机将上述患者分为两组,观察组和对照组。对照组患者给予支气管哮喘急性发作常规治疗:解痉、平喘、糖皮质激素、控制感染等;观察组在对照组治疗的基础上给予生脉注射液60ml加入250ml生理盐水中静脉滴注,每天1次。两组患者共治疗14天。在治疗期间观察患者临床症状改善情况,并定期测定患者肺功能。结果两组患者总有效率比较,差异有统计学意义,P<0.05。结论生脉注射液辅助可以显著改善支气管哮喘急性发作期患者临床症状,提高肺功能,临床治疗效果显著,值得借鉴。

Objective To discuss the clinical effect of adjuvant therapy of sheng mai injection for the treatment of acute attack of bronchial asthma. Methods 92 cases with acute attack of bronchial asthma from Jan. 2008 to Dec. 2009 were randomly divided into observation group and control group. Control group was given conventional treatment, such as spasmolysis, asthma relieving, glucocorticoid and infection controlling, while observation group was injected 60ml sheng mai injection added into 250ml normal saline on the basis of control group, once daily. Both groups were treated for 2 weeks. Patients＇ clinical symptoms were observed and their pulmonary function were measured regularly. Results The difference of two groups＇ total effective rates had statistical significance, P〈0.05. Conclusion Adjuvant therapy of sheng mai injection can obviously improve patients＇ clinical symptoms and lung function. The clinical effect is obvious, which is worth learning.